Corcept Therapeutics News (NASDAQ:CORT)

DateTimeSource
Headline
02/22/20184:05PMGLOBECorcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial
MENLO PARK, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the stress hormone cortisol, today reported its... More...>>
02/15/20184:05PMGLOBECorcept Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results, Provide Corporate Update, Host Conferen...
MENLO PARK, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report its 2017 financial results and provide a corporate update on February 22, 2018.  The Company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time... More...>>
02/01/20188:30AMGLOBECorcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenu...
2017 revenue of $159.2 million, an increase of 96 percent from 2016Fourth quarter revenue of $53.3 million, an increase of 124 percent from fourth quarter 2016 Cash and marketable securities at December 31, 2017 of $104.0 million2018 revenue guidance of $275 – 300 million MENLO PARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE... More...>>
12/20/20175:44PMPRNUSInteractive Brokers Group Set to Join S&P MidCap 400; Alarm.com Holdings and Corcept Therapeutics to Join S&P SmallCap 600
Interactive Brokers Group Set to Join S&P MidCap 400; Alarm.com Holdings and Corcept Therapeutics to Join S&P SmallCap 600 PR Newswire NEW YORK, Dec. 20, 2017 NEW YORK, Dec. 20, 2017 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: S&P... More...>>
11/02/20174:05PMGLOBECorcept Therapeutics Announces Third Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Upda...
MENLO PARK, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the stress hormone cortisol, today reported its... More...>>
10/26/20174:05PMGLOBECorcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
MENLO PARK, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report its third quarter 2017 financial results and provide a corporate update on November 2, 2017. The Company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific... More...>>
08/01/20174:05PMGLOBECorcept Therapeutics Announces Second Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Upd...
Commercial & Financial Highlights Revenue of $35.6 million in second quarter 2017, an increase of 80 percent from second quarter 2016 2017 revenue guidance increased by $20 million, to $145-155 millionGAAP net income of $0.10 per share, compared to $0.01 per share in second quarter 2016Non-GAAP net income of $0.13... More...>>
07/25/20174:05PMGLOBECorcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
MENLO PARK, Calif., July 25, 2017 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report its second quarter 2017 financial results and provide a corporate update on August 1, 2017. The Company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific... More...>>
04/22/201510:03AMTMF3 Soaring Biotech Stocks Under $10 -- Are They Buys?
http://www.fool.com/investing/general/2015/04/22/3-soaring-biotech-stocks-under-10-are-they-buys.aspx?source=eptadnlnk0000002 More...>>
04/21/20153:15AMARNCorcept Therapeutics Coverage Initiated by Analysts at FBR & Co. (CORT)
http://tickerreport.com/banking-finance/462541/corcept-therapeutics-coverage-initiated-by-analysts-at-fbr-co-cort/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V:us D:20180225 13:44:54